Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo-Reference-Cited by-同舟云学术

Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo

Published:2021-02-18 Issue:6 Volume:46 Page:1220-1228
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol.

Author:

Auvity Sylvain,Goutal Sébastien,Caillé Fabien,Vodovar Dominique,Pruvost Alain,Wimberley Catriona,Leroy Claire,Tonietto Matteo,Bottlaender Michel,Tournier Nicolas^ORCID

Funder

Agence Nationale de la Recherche

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/s41386-021-00976-w.pdf

Reference60 articles.

1. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008;11:S133–153.

2. Helm S, Trescot AM, Colson J, Sehgal N, Silverman S. Opioid antagonists, partial agonists, and agonists/antagonists: the role of office-based detoxification. Pain Physician. 2008;11:225–35.

3. Wakeman SE, Barnett ML. Primary care and the opioid-overdose crisis—buprenorphine myths and realities. N Engl J Med. 2018;379:1–4.

4. Olson KM, Duron DI, Womer D, Fell R, Streicher JM. Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids. PloS ONE. 2019;14:e0217371.

5. Volpe DA, McMahon Tobin GA, Mellon RD, Katki AG, Parker RJ, Colatsky T, et al. Uniform assessment and ranking of opioid μ receptor binding constants for selected opioid drugs. Regul Toxicol Pharm. 2011;59:385–90.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain PET imaging using ¹¹C-flumazenil and ¹¹C-buprenorphine does not support the hypothesis of a mutual interaction between buprenorphine and benzodiazepines at the neuroreceptor level;Journal of Cerebral Blood Flow & Metabolism;2023-12-14

2. Endogenous opiates and behavior: 2021;Peptides;2023-06

3. Validation of a pharmacological imaging challenge using 11C-buprenorphine and 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography to study the effects of buprenorphine to the rat brain;Frontiers in Neuroscience;2023-05-10

4. A pharmacological imaging challenge based on 11C-buprenorphine PET-MRI to explore the response to opioids in humans;European Journal of Nuclear Medicine and Molecular Imaging;2023-05-06

5. Amoxapine-Loaded Solid Lipid Nanoparticles with Superior Preclinical Pharmacokinetics for Better Brain Delivery: LC-MS/MS and GC-MS Analysis;ACS Chemical Neuroscience;2023-04-07